• Intratracheal Budesonide for Extremely Preterm Infants

  • 2024/11/11
  • 再生時間: 8 分
  • ポッドキャスト

Intratracheal Budesonide for Extremely Preterm Infants

  • サマリー

  • Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women’s Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH.

    Related Content:

    • Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants
    続きを読む 一部表示

あらすじ・解説

Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women’s Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH.

Related Content:

  • Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants

Intratracheal Budesonide for Extremely Preterm Infantsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。